TE_12393

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family L1HS_5end
TE superfamily L1
TE class LINE
Gene -
Class Intergenic
Coding Non-coding
Tumor-specific score 173.85
Counts of samples TCGA_tumor:616; TCGA_normal:1; GTEx:2
TSS chr5(+):30823612



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_12393.11 - Intergenic Non-coding Non-coding chr5(+):30823613,30823740,30824408,30824569,30825749,30825836,30844957,30844977
teRNA_12393.12 - Intergenic Non-coding Non-coding chr5(+):30823613,30823740,30824408,30824569,30825749,30825836,30896207,30896279,30947401,30947421
teRNA_12393.13 - Intergenic Non-coding Non-coding chr5(+):30823613,30823740,30824408,30824569,30825749,30825836,30844957,30845075,30896207,30896279,30947602,30947622
teRNA_12393.14 - Intergenic Non-coding Non-coding chr5(+):30823613,30823740,30824408,30824569,30825749,30825836,30896207,30896279,30947602,30947622
teRNA_12393.15 - Intergenic Non-coding Non-coding chr5(+):30823613,30823740,30824408,30824569,30825749,30825836,30896207,30896279,30943485,30944211,30947401,30947421
teRNA_12393.16 - Intergenic Non-coding Non-coding chr5(+):30823613,30823740,30824408,30824569,30825749,30825836,30830325,30830345
teRNA_12393.17 - Intergenic Non-coding Non-coding chr5(+):30823613,30823740,30824408,30824569,30825749,30825836,30842452,30842472
teRNA_12393.18 - Intergenic Non-coding Non-coding chr5(+):30823613,30823740,30824408,30824569,30825749,30825836,30844957,30845075,30896207,30896279,30947401,30947488,30947602,30947622
teRNA_12393.19 - Intergenic Non-coding Non-coding chr5(+):30823613,30823740,30824408,30824569,30825749,30825836,30896207,30896279,30947401,30947488,30947602,30947622
teRNA_12393.20 - Intergenic Non-coding Non-coding chr5(+):30823613,30823740,30824408,30824569,30825749,30825836,30896207,30896279,30913312,30913332


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).